Literature DB >> 16145125

Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.

Cidália Pina-Vaz1, Sofia Costa-de-Oliveira, Acácio G Rodrigues, Ana Espinel-Ingroff.   

Abstract

A cytometric approach to determine the susceptibilities of Candida spp. and Cryptococcus neoformans to voriconazole, itraconazole, and caspofungin is described. A total of 63 clinical isolates with different susceptibility patterns were exposed for 1, 2, 4, and 6 h to serial concentrations of each antifungal agent, followed by staining with two fluorescent probes: propidium iodide (PI) and FUN-1. FUN-1 was able to identify the susceptibility patterns of the assayed strains to the three agents after 1 h. PI penetrated a maximum of 50% of the cells treated with PI, at the highest concentration of caspofungin, 16 mug/ml, after 6 h of incubation (this percentage varied with the strain and was drug concentration and time of incubation dependent) and did not stain cells treated with high concentrations of either azole after 6 h. The use of FUN-1 appears to be an excellent fast and reliable alternative to the classical dilution method for determining the susceptibility of Candida spp. and C. neoformans to these three antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145125      PMCID: PMC1234075          DOI: 10.1128/JCM.43.9.4674-4679.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.

Authors:  Rama Ramani; Madhurama Gangwar; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test.

Authors:  R Ramani; V Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

Authors:  E J Ernst; M E Klepser; M E Ernst; S A Messer; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-02       Impact factor: 2.803

4.  Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals.

Authors:  C Pina-Vaz; F Sansonetty; A G Rodrigues; S Costa-Oliveira; C Tavares; J Martinez-de-Oliveira
Journal:  Clin Microbiol Infect       Date:  2001-11       Impact factor: 8.067

5.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.

Authors:  Cidália Pina-Vaz; Filipe Sansonetty; Acácio G Rodrigues; J Martinez-DE-Oliveira; António F Fonseca; Per-Anders Mårdh
Journal:  J Med Microbiol       Date:  2000-09       Impact factor: 2.472

7.  In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.

Authors:  M A Pfaller; D J Diekema; S A Messer; R J Hollis; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

8.  Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy.

Authors:  Cidália Pina-Vaz; Filipe Sansonetty; Acácio G Rodrigues; Sofia Costa-DE-Oliveira; J Martinez-DE-Oliveira; António F Fonseca
Journal:  J Med Microbiol       Date:  2001-04       Impact factor: 2.472

9.  Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.

Authors:  G Morace; G Amato; F Bistoni; G Fadda; P Marone; M T Montagna; S Oliveri; L Polonelli; R Rigoli; I Mancuso; S La Face; L Masucci; L Romano; C Napoli; D Tatò; M G Buscema; C M C Belli; M M Piccirillo; S Conti; S Covan; F Fanti; C Cavanna; F D'Alò; L Pitzurra
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Caspofungin.

Authors:  Stanley C Deresinski; David A Stevens
Journal:  Clin Infect Dis       Date:  2003-05-19       Impact factor: 9.079

View more
  13 in total

1.  Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.

Authors:  Muireann Coen; Jennifer Bodkin; Damla Power; William A Bubb; Uwe Himmelreich; Philip W Kuchel; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

2.  Evaluation of Giardia duodenalis viability after metronidazole treatment by flow cytometry.

Authors:  Joana Barbosa; Acácio Gonçalves Rodrigues; Maria José Pérez; Cidália Pina-Vaz
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-11-21       Impact factor: 2.743

3.  Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.

Authors:  L A Vale-Silva; P Pinto; V Lopes; H Ramos; E Pinto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-10       Impact factor: 3.267

4.  Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.

Authors:  Karuna Singh
Journal:  Folia Microbiol (Praha)       Date:  2020-07-02       Impact factor: 2.099

5.  The effect of cinnamaldehyde on the growth and the morphology of Candida albicans.

Authors:  Yuuki Taguchi; Yayoi Hasumi; Shigeru Abe; Yayoi Nishiyama
Journal:  Med Mol Morphol       Date:  2013-01-17       Impact factor: 2.309

6.  Detection of Legionella pneumophila on clinical samples and susceptibility assessment by flow cytometry.

Authors:  I Faria-Ramos; S Costa-de-Oliveira; J Barbosa; A Cardoso; J Santos-Antunes; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-28       Impact factor: 3.267

7.  Cytometric approach for detection of Encephalitozoon intestinalis, an emergent agent.

Authors:  Joana Barbosa; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

8.  New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B.

Authors:  Rita Teixeira-Santos; Elisabete Ricardo; Susana Gomes Guerreiro; Sofia Costa-de-Oliveira; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

Review 9.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

10.  Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.

Authors:  Colin J Ingham; Sjoukje Boonstra; Suzanne Levels; Marit de Lange; Jacques F Meis; Peter M Schneeberger
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.